Rapid Decrease of Plasma Galectin-9 Levels in Patients with Acute HIV Infection after Therapy
Open Access
- 1 January 2012
- journal article
- case report
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 228 (2), 157-161
- https://doi.org/10.1620/tjem.228.157
Abstract
Acute HIV-1 infection is often diagnosed as infectious mononucleosis and the symptoms resolve spontaneously after varying periods of time. After the infection of HIV-1 through the mucosa, the characteristic clinical symptoms and laboratory markers of acute HIV-1 infection appear in each patient through a complicated virus-host interaction. To understand the host responses, we measured two unique proinflammatory cytokines, galectin-9 (Gal-9) and osteopontin (OPN). A β-galactoside-binding mammalian lectin, Gal-9, reduces pro-inflammatory type-1 helper T (Th1) cells and Th17 cells and increases anti-inflammatory regulatory T cells. The plasma level of Gal-9 is known to be associated with HIV-1 viral load in chronic HIV-1 infection. On the contrary, osteopontin induces Th1/Th17 cells and promotes tissue inflammation. OPN is synthesized by variety of cells in the body, and dendritic cells are known to synthesize OPN in HIV-1 infected individuals. It was hypothesized that Gal-9 and/or OPN could be not only immune-modulators but also novel biomarkers of acute HIV-1 infection. We experienced 3 patients with acute HIV-1 and measured the levels of Gal-9 and OPN periodically before and after antiretroviral treatment. The results showed that the plasma levels of Gal-9 were extremely elevated [more than 2,300 pg/ml (normal range < 46 pg/ml)] in all three acute HIV-1 infected individuals and decreased rapidly after treatment. The changes in the OPN levels were less marked. In conclusion, the plasma levels of Gal-9 may be predictive of a severe inflammation status during the acute phase of HIV-1 infection and could be a potential biomarker during acute infection.Keywords
This publication has 16 references indexed in Scilit:
- Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infectionBlood, 2012
- Involvement of osteopontin and its signaling molecule CD44 in clinicopathological features of adult T cell leukemiaLeukemia Research, 2011
- Acute HIV-1 InfectionNew England Journal of Medicine, 2011
- Acute Hepatitis B and Acute HIV Coinfection in an Adult Patient: A Rare Case ReportCase Reports in Medicine, 2010
- Tim3 binding to galectin-9 stimulates antimicrobial immunityThe Journal of Experimental Medicine, 2010
- Role of osteopontin in synovial Th17 differentiation in rheumatoid arthritisArthritis & Rheumatism, 2010
- Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathologyExperimental Dermatology, 2009
- Persistent Elevation of Plasma Osteopontin Levels in HIV Patients Despite Highly Active Antiretroviral TherapyThe Tohoku Journal of Experimental Medicine, 2009
- Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infectionThe Journal of Experimental Medicine, 2008
- Potential Roles of Follicular Dendritic Cell–Associated Osteopontin in Lymphoid Follicle Pathology and Repair and in B Cell Regulation in HIV?1 and SIV InfectionThe Journal of Infectious Diseases, 2005